Study on the method to avoid infusion-site adverse events following chemotherapeutic treatment with epirubicin and fosaprepitant using immortalized human umbilical vein endothelial cells
Article in Oncology Letters (September 2022)
The most recent citing publications are shown below. View all 18 publications that cite this research output on Dimensions.
Article in Oncology Letters (September 2022)
Article in The Journal of Vascular Access (November 2021)
Article in The Journal of Maternal-Fetal & Neonatal Medicine (October 2021)